Creating a collaborative research environment, enabling the next scientific breakthrough 

Life-changing discoveries are born where people, ideas and technology meet. Imperiais investing in these meeting points, creating new spaces grounded in cutting-edge digital infrastructure. 

Philanthropy will transform the scale of 海角社区’s research output – bringing together researchers and scientists across disciplines, and connecting them with businesses, society and policymakers to translate scientific innovation into real-world application. With your support, we can accelerate the impact of new ideas and discoveries and create a safer, smarter and more sustainable future.  

Transformative discoveries start at Imperia

Philanthropy at 海角社区 gives brilliant minds the interdisciplinary spaces and platforms needed to foster true collaboration. 

The Sir Michael Uren鈥疊iomedical Engineering鈥疕ub鈥痠s one of these spaces - bringing together over 500鈥疘mperiaresearchers,鈥痚ngineers鈥痑nd clinicians to鈥痙evelop new and affordable medical technologies.鈥疢ade possible by a landmark donation of £40 million from the late Imperiaalumnus Michael Uren OBE and his Foundation, the Hub is home to many interdisciplinary teams, including the the鈥疢Sk鈥疞ab, focused on musculoskeletal health and degeneration.鈥�鈥� 

The team of surgeons, physiotherapists, scientists and engineers at the鈥疢Sk鈥疞ab is behind鈥痶he new H1鈥痠mplant which has opened up less invasive hip resurfacing surgery to women.鈥疍esigned using ceramic rather than metal鈥痶o coat the鈥痶wo faces of the hip joint, the new H1 implant can be shaped to better fit women’s hip shapes.鈥�鈥� 

As the first hip resurfacing device to receive the CE mark, the H1 implant鈥痗an now be sold to clinics throughout Europe and other countries that recognise the CE mark, making life-changing treatment widely available.鈥�

The development of the H1 implant shows what can be achieved when engineers, scientists, clinicians and industry work together on a shared goal. It’s a wonderful and concrete example of bench to bedside translational research coming from the Sir Michael Uren Hub. Dr Susannah Clarke Research Fellow at the Department of Surgery and Cancer, Co-Founder and CEO of Embody Orthopaedic